Nu Wave Investment Management, LLC Incyte Corp Transaction History

Nu Wave Investment Management, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$66.02 - $79.71 $19,277 - $23,275	-292 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$63.34 - $74.11 $18,495 - $21,640	292 New	292 $21,000
Q3 2021 Oct 18, 2021	SELL	$68.67 - $84.02 $34,747 - $42,514	-506 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$79.87 - $87.53 $40,414 - $44,290	506 New	506 $43,000
Q1 2021 Apr 09, 2021	SELL	$76.02 - $100.5 $21,665 - $28,642	-285 Closed	0 $0
Q4 2020 Jan 11, 2021	SELL	$80.74 - $97.7 $42,549 - $51,487	-527 Reduced 64.9%	285 $25,000
Q3 2020 Oct 23, 2020	SELL	$85.07 - $109.69 $100,382 - $129,434	-1,180 Reduced 59.24%	812 $73,000
Q2 2020 Jul 13, 2020	BUY	$74.18 - $108.93 $147,766 - $216,988	1,992 New	1,992 $201,000
Q1 2020 Apr 14, 2020	SELL	$63.18 - $85.97 $460,834 - $627,065	-7,294 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $522,382 - $684,589	7,152 Added 5036.62%	7,294 $637,000
Q3 2019 Oct 15, 2019	BUY	$72.82 - $86.52 $4,660 - $5,537	64 Added 82.05%	142 $11,000
Q2 2019 Jul 18, 2019	BUY	$73.52 - $88.7 $5,366 - $6,475	73 Added 1460.0%	78 $7,000
Q1 2019 Apr 11, 2019	SELL	$63.56 - $88.17 $1,398 - $1,939	-22 Reduced 81.48%	5 $0
Q4 2018 Jan 22, 2019	SELL	$58.5 - $69.94 $88,920 - $106,308	-1,520 Reduced 98.25%	27 $2,000
Q3 2018 Oct 23, 2018	BUY	$61.75 - $74.23 $95,033 - $114,239	1,539 Added 19237.5%	1,547 $107,000
Q2 2018 Aug 01, 2018	BUY	$60.85 - $83.98 $486 - $671	8 New	8 $1,000
Q1 2018 May 02, 2018	SELL	$83.06 - $100.98 $414,469 - $503,890	-4,990 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$93.56 - $116.6 $466,864 - $581,834	4,990	4,990 $473,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.